Alexander Burchardt

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With <i>FLT3</i>–Internal Tandem Duplication Mutation (SORMAIN)

Andreas Burchert, Gesine Bug, Lea Fritz et al. · Journal of Clinical Oncology · 2020 · 538 citations · Full text

Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

Richard F. Schlenk, Daniela Weber, Walter Fiedler et al. · Blood · 2018 · 283 citations · Full text

Pharmacokinetics, Safety, and Efficacy of Posaconazole in Patients with Persistent Febrile Neutropenia or Refractory Invasive Fungal Infection

Andrew J. Ullmann, Oliver A. Cornely, Alexander Burchardt et al. · Antimicrobial Agents and Chemotherapy · 2006 · 271 citations · Full text

Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group

Nadežda Basara, H. Baurmann, Karin Kolbe et al. · Bone Marrow Transplantation · 2005 · 95 citations · Full text

Antithymocyte Globulin, Graft-versus-host Disease, Transplantation +10

Bendamustine plus rituximab (B-R) versus CHOP plus rituximab (CHOP-R) as first-line treatment in patients with indolent lymphomas: Nine-year updated results from the StiL NHL1 study.

Mathias Rummel, Georg Maschmeyer, Arnold Ganser et al. · Journal of Clinical Oncology · 2017 · 78 citations

Hematological Malignancy, Lymphoid Neoplasia, Surgical Oncology +14